LEBSA is an innovative European laboratory
dedicated to the synthesis, manufacture and commercialization
of Active Pharmaceutical Ingredients (APIs).
With 68 years of experience, we have built an excellent reputation in the global pharmaceutical market for generic API manufacturing in Europe. Based in Barcelona, Spain, we export up to 90% of our production.
High quality and outstanding customer care define everything we do as an API manufacturer in Europe. We continuously seek out new challenges, focusing on niche molecules, R&D development and new flow-chemistry processes.
|Sales markets||Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America|
|Affiliated categories:||API Contract Manufacturing |Exclusive Synthesis of APIs |APIs More|
Our Top products
Mianserin (CAS number 24219-97-4) is a antidepressant agent under development by our R&D team (expected Q1 2020). Mianserin will be available with full regulatory support, including CEP/ EU DMF/ GMP certificate. LEBSA is your reputed API manufacturer partner and well kno...More info
LEBSA manufactures in compliance with full GMP conditions a range of Active Pharmaceutical Ingredients (APIs) which includes Amisulpride (CAS number 71675-85-9). It is a neuroleptic/ antipsychotic agent manufactured in our unique European GMP manufacturing plant loc...More info
News about Lebsa
22 Jul 2019
New Certificate of Suitability (CEP) of Tiapride hydrochloride
LEBSA recently got the Certificate of Suitability (CEP) -R0-CEP 2018-066-Rev 00- by EDQM of Tiapride hydrochloride (CAS 51012-33-0) to offer the best quality product to our customers at the most affordable price.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation